Latest

Monopolies are causing “artificial rationing” in COVID-19 crisis as 3 biggest global vaccine giants sit on sidelines

Johannesburg: 5 February 2021 The supply of safe and effective vaccines for all is being artificially rationed because of the protection of exclusive rights and monopolies of pharmaceutical corporations, the People’s Vaccine Alliance said today. The alliance warned that the three biggest vaccine companies in the world are largely sitting on the sidelines – they […]

READ MORE

SAVE LIVES NOW: SUPPORT THE COVID-19 TRIPS WAIVER

Press Release 1 February 2021 The Doha Declaration states that countries can and should interpret the Agreement on the Trade Related Aspects of Intellectual Property Rights (TRIPS) in a manner that protects public health, including ensuring access to essential medicines for all. So why are the representatives of the USA, UK, EU, Australian Japan, Brasil […]

READ MORE

South Africa’s patent laws threaten access to future COVID-19 medicines

Johannesburg, 18th May — In a letter to President Cyril Ramaphosa published today, the Fix the Patent Laws (FTPL) coalition outlined major concerns about South Africa’s ability to access future treatments or vaccines for COVID-19. They point out that the country’s outdated patent laws ensure that when effective treatments become available, they will likely be too […]

READ MORE

COVID-19: The time for procrastination over patents is over

This article was originally published in Spotlight here. 20th April 2020 | Prof Yousuf Vawda and Prof Brook K. Baker The path to patent law reform in South Africa has been long and arduous. But the need for finalisation of legislation is now even more urgent given the COVID-19 pandemic and the expected rush to […]

READ MORE

COVID-19: Patent victories from HIV fight are now more relevant than ever

This article was originally published on Spotlight here. 15th April 2020 | Catherine Tomlinson Around the turn of the century developing countries, led by African countries, dramatically fought for and won safeguards to promote access to medicines in international trade law. These safeguards are now being heralded by lawmakers around the world as critical legal […]

READ MORE

Activists demand Johnson & Johnson drop the price of vital TB medicine bedaquiline

Contact: Ngqabutho Mpofu (Treatment Action Campaign): 27 61 807 6443| ngqabutho.mpofu@tac.org.za Lotti Rutter (Health GAP): +27 82 065 5842| lotti@healthgap.org (Durban, South Africa)— Today activists stormed the corporate stall of multinational pharmaceutical company Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) at the 9th South African AIDS Conference. The activists demanded that Janssen urgently drop the price of […]

READ MORE